Novel Stent Technologies in Search of a TARGET: Balancing Needs for Patient and Market?

Affiliations

¹ Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. Electronic address: joner@dhm.mhn.de.
² Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

Free article

Editorial

Michael Joner et al. JACC Cardiovasc Interv. 2019.

Free article

. 2019 Sep 9;12(17):1688-1690.

doi: 10.1016/j.jcin.2019.05.005. Epub 2019 May 22.

¹ Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. Electronic address: joner@dhm.mhn.de.
² Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

No abstract available

Keywords: biodegradable polymer; drug-eluting stent; percutaneous coronary intervention.

Comment on

2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.
Xu B, Saito Y, Baumbach A, Kelbæk H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Lansky A, Wijns W; TARGET AC Investigators. Xu B, et al. JACC Cardiovasc Interv. 2019 Sep 9;12(17):1679-1687. doi: 10.1016/j.jcin.2019.05.001. Epub 2019 May 22. JACC Cardiovasc Interv. 2019. PMID: 31129092 Clinical Trial.